In the ILIAS ANOCA trial, using CFT to guide treatment according to ANOCA endotype led to larger QoL gains over 6 months.

Discover 7 treatments for ischemic heart disease that are saving lives. From cutting-edge medications to advanced procedures changing cardiac care forever.

The coronary heart disease diagnostic imaging devices market is projected to grow at a CAGR of ~7% over the forecast period.

A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United ...

A total of 300 patients across the three institutions will be involved in the year-long trial. Read more at straitstimes.com.

Johnson & Johnson has put forward a clinical study exploring the use of its Shockwave Medical division’s vessel-clearing ...

University of Iowa Health Care has become the first in Iowa to offer drug-coated balloon therapy for patients with blockages ...

Scripps Research study combines AI, genomics, and health records to create personalized heart attack risk predictions. ABC ...

Philips RADIQAL trial May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical ...